Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • Data Privacy
  • Français
  • my CNW 
    • Login
    • Register
  • Client Login 
    • Online Member Centre
    • Next Gen Communications Cloud
    • Cision Communications Cloud®
  • Sign Up
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
Advanced Search
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Canadian Federal Government
      • Canadian Municipal Government
      • Canadian Provincial Government
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

  • Advanced Search
  • Overview
  • Multichannel Amplification
  • Monitoring
  • Distribution
  • Multimedia
  • Guaranteed Paid Placement
  • AI Tools
  • IR
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Hamburger menu
  • Cision Canada
  • Send a Release
  • FR
    • Phone

    • 877-269-7890 from 8 AM - 10 PM ET

    • ALL CONTACT INFO
    • Contact Cision

      877-269-7890
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • Overview
  • Multichannel Amplification
  • Monitoring
  • Distribution
  • Multimedia
  • Guaranteed Paid Placement
  • AI Tools
  • IR
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR

$22 million to heal more children with cancer, better Français


News provided by

CHU Sainte-Justine Foundation

May 18, 2017, 12:00 ET

Share this article

Share toX

Share this article

Share toX

From left to right: Mr. Pierre Boivin, Ms. Maud Cohen, Dr. Elie Haddad, Pr. Daniel Sinnett, Dr. Michel Duval, Me. Richard Laramée, President of the Board of Directors of the Charles-Bruneau Foundation, Dr. Fabrice Brunet, Mr. Pierre Bruneau, board member and spokesperson for the Charles-Bruneau Foundation, Ms. Rébecca Dumont, executive director of the Charles-Bruneau Foundation, Noémie Roberge, Ms. Myriam Bédard, Elyjah Tricoire, Mr. Yaroslav Yurkevych and Charlotte Roberge. (CNW Group/CHU Sainte-Justine Foundation)
From left to right: Mr. Pierre Boivin, Ms. Maud Cohen, Dr. Elie Haddad, Pr. Daniel Sinnett, Dr. Michel Duval, Me. Richard Laramée, President of the Board of Directors of the Charles-Bruneau Foundation, Dr. Fabrice Brunet, Mr. Pierre Bruneau, board member and spokesperson for the Charles-Bruneau Foundation, Ms. Rébecca Dumont, executive director of the Charles-Bruneau Foundation, Noémie Roberge, Ms. Myriam Bédard, Elyjah Tricoire, Mr. Yaroslav Yurkevych and Charlotte Roberge. (CNW Group/CHU Sainte-Justine Foundation)
Logo: Fondation CHU Sainte-Justine (CNW Group/CHU Sainte-Justine Foundation)
Logo: Fondation CHU Sainte-Justine (CNW Group/CHU Sainte-Justine Foundation)
Logo: CHU Sainte-Justine (CNW Group/CHU Sainte-Justine Foundation)
Logo: CHU Sainte-Justine (CNW Group/CHU Sainte-Justine Foundation)
Logo: Fondation Charles-Bruneau (CNW Group/CHU Sainte-Justine Foundation)
Logo: Fondation Charles-Bruneau (CNW Group/CHU Sainte-Justine Foundation)

The Charles-Bruneau Foundation makes the largest donation in the CHU Sainte-Justine's history
to support immuno-hemato-oncology research

MONTREAL, May 18, 2017 /CNW Telbec/ - The Charles-Bruneau Foundation has signed a historic agreement pledging
$22 million to immuno-hemato-oncology research at the CHU Sainte-Justine, which will enable sequencing of the human genome in children and teenagers afflicted with cancer. This will help to understand the molecular characteristics of each individual tumour, provide a precise diagnosis, identify anomalies and provide treatment through targeted therapies. This strategic use of precision medicine paves the way for the discovery of biological markers of efficacy, genetic markers that, once detected, provide clues as to which treatment will be most effective and how the disease is likely to evolve, with the goal of improving quality of life after recovery, without side effects or complications. The Foundation's exceptional commitment, which provides the means to develop individualized therapeutic treatments, was celebrated with great emotion today at the official inauguration of the Charles-Bruneau Immuno-Hemato-Oncology Research Unit at the CHU Sainte-Justine.

The CHU Sainte-Justine's team of pediatric oncology researchers and clinicians is actively involved in major North American clinical research consortiums. The research program enabled by this donation will allow Sainte-Justine's teams to consolidate their leadership and help determine, right here in Quebec, how best to treat and cure children with cancer. These funds enable the CHU Sainte-Justine to accelerate the pace of scientific discoveries, offer the most innovative treatments, and increase the speed of knowledge transfer across the entire health network, at both the national and international levels.

Identification of therapeutic response determinants

"First, a genomic study will allow us to examine all the genes, the entire genetic life of each patient, to identify the molecular bases of the child's disease, define the potential resistance to treatment in the short- and long-term depending on the genetic profile, and identify any side effects of treatment in order to develop individualized therapeutic interventions, or precision medicine," said Pr. Daniel Sinnett, Cancer Genetics Researcher, head of the Viral and Immune Disorders and Cancers Research Axis and co-head of the Immune Diseases and Cancer Area of Excellence.

Immunotherapy and targeted therapies

"If cancer develops in a child, it is because the immune system has failed to surround and destroy it. The second phase of treatment focuses on two new approaches based on a completely different system than that of conventional chemotherapy: immunotherapy and targeted therapies. The first uses the child's immune system, their own defense system, and reprograms it through the genetic modification of cells, so that it can attack the cancerous cells the same way it would normally attack a virus," said Dr. Elie Haddad, clinician in the Immunology and Allergy Clinic at the CHU Sainte-Justine and co-head of the Cancer and Immune Disorders Area of Excellence.

"The second approach, which works in concert with the first, focuses on targeted treatments according to the patient's molecular profile, the goal of which is to destroy only the cancerous cells without damaging any of the body's healthy cells, to prevent the child from experiencing aftereffects," added Dr. Michel Duval, co-head of the CHU Sainte-Justine's Hemato-Oncology Department.

Quality of life and psychosocial research

"How can we measure the distress a family feels when they receive a diagnosis, or their rising hope when there is good news? Quality of life is measurable," said Mr. Serge Sultan, psychologist and researcher at the CHU Sainte-Justine.

"Patients are key players in the advancement of the quality of care and it is our duty to support the child, parents, grandparents and siblings through such a difficult time. Psychosocial research is our third weapon in the fight against cancer and the improvement of quality of life for children in Quebec," said Dr. Michel Duval.

Medicine of tomorrow

"As a super-regional oncology centre, the CHU Sainte-Justine is responsible for the diagnosis and treatment of more than 60% of pediatric cancer cases in Quebec. The impact of these illnesses on the child, the creativity of our approaches, our success when it comes to therapies and the transdisciplinarity of our researchers form the basis of our scientific programming. We're working on the medicine of tomorrow today, and it promises to be highly individualized. With personalized treatments that are better adapted to each case, therapies will be more effective, the chances of a cure are greater, the incidence of secondary effects is reduced, and we can also hope to reduce the impact on health care costs in the long term," stated Dr. Fabrice Brunet, CEO of the CHU Sainte-Justine.

Ms. Maud Cohen, CEO of the CHU Sainte-Justine Foundation, was delighted to acknowledge the incredible pledge of $22 million from the Charles-Bruneau Foundation, which, through its commitment, engagement and desire for innovation, healing and improving the well-being of children with cancer, supports and highlights the interdisciplinary approach of the CHU Sainte-Justine's immuno-hemato-oncology research team, as well as their partnership with patients and families.

"Today is a great day for pediatric oncology in Quebec. With this donation, the Charles-Bruneau Foundation has brought philanthropy to new heights to match the ambitions of the CHU Sainte-Justine. Thank you for inspiring hope for a healthy future. The CHU Sainte-Justine Foundation is proud to stand with the Charles-Bruneau Foundation in the fight against childhood cancer. This support will allow the CHU Sainte-Justine's pediatric oncology researchers and clinicians to immediately undertake projects to ensure that children in Quebec have the first access to what will become the standard in health care in the next five years," she said.

Charles's lasting dream

"Before his death, Charles asked me to promise that I would continue his fight. At the time, I had no idea of the journey I was about to embark on, but that's why today, 27 years after establishing the Foundation that bears his name, we remain committed to our mission with a donation of $22 million towards research. Our goals are to cure the 20% of children whose cancer is resistant to treatment, and to improve quality of life for children in remission so that they can achieve a total cure, without side effects or complications. I am convinced that one day, all children will see their dream of a cure come true," said Mr. Pierre Bruneau, board member and spokesperson for the Charles-Bruneau Foundation.

"The Sainte-Justine team, in collaboration with its partners and using a network-based approach, is now expanding its research and teaching efforts in the field of pediatric oncology. Today, we know that more discoveries will be made in the next 10 years than in the last 100. We firmly believe that a partnership with such a renowned institution to create this immuno-hemato-oncology research unit will transform current treatments for pediatric cancer. Researchers will now be able to push the boundaries of knowledge even further and accelerate knowledge transfer from the laboratory to the patient's bedside," stated Rébecca Dumont, executive director of the Charles-Bruneau Foundation.

For the Charles-Bruneau Foundation, being able to contribute so generously to immuno-hemato-oncology research is a means of continuing the fight against pediatric cancer in Quebec and improving patients' quality of life after treatment, a goal which is at the heart of its mission.

The CHU Sainte-Justine and the CHU Sainte-Justine Foundation gratefully acknowledge this historic support from the Charles-Bruneau Foundation, which enables the CHU Sainte-Justine's teams to continue to heal more children, better.

About the CHU Sainte-Justine Foundation

The CHU Sainte-Justine Foundation's mission is to engage the community and support the CHU Sainte-Justine in its pursuit of excellence and its commitment to providing children and mothers with one of the highest levels of healthcare in the world, now and in the future. fondation-sainte-justine.org/en/

About the CHU Sainte-Justine

The Sainte-Justine university hospital centre (CHU Sainte-Justine) is the largest mother-child centre in Canada and the second largest pediatric hospital in North America. A member of the Université de Montréal extended network of excellence in health (RUIS), Sainte-Justine has 5,457 employees, including 1,532 nurses and nursing assistants; 1,000 other healthcare professionals; 520 physicians, dentists and pharmacists; 822 residents  and over 204 researchers; 411 volunteers; and 4,416 interns and students in a wide range of disciplines. Sainte-Justine has 484 beds, including 67 at the Centre de réadaptation Marie Enfant (CRME), the only exclusively pediatric rehabilitation centre in Quebec. The World Health Organization has recognized CHU Sainte-Justine as a "health promoting hospital." chusj.org

About the Charles-Bruneau Foundation

Established in 1990, the Charles-Bruneau Foundation's mission us to fund research for and support the development of projects related to pediatric hemato-oncology in Quebec. The Foundation believes that the thousands of children afflicted with cancer have the right to the best care available, throughout the province. It is active in the four university hospital centres in Quebec: the CHU Sainte-Justine, the CHU Québec-Université Laval, the CIUSSS of the Estrie-CHUS and the Montreal Children's Hospital. charlesbruneau.qc.ca

SOURCE CHU Sainte-Justine Foundation

Information: CHU Sainte-Justine, Mélanie Dallaire, Senior Advisor, External Communications, 514-345-7707 (direct), 514-415-5727 (media pager), [email protected]; CHU Sainte-Justine Foundation, Delphine Brodeur, Director, Communication, Public Relations and Donor Relations, 514-345-4931, ext. 4356, [email protected]; Charles-Bruneau Foundation, Marie-Claude Lachance, Director, Events and Communications, 514-256-0404, ext. 230, 514-219-6350 (cell), [email protected]

Related Links

www.fondation-sainte-justine.org/fr/

Modal title

Organization Profile

CHU Sainte-Justine Foundation

    Also from this source

  • Philanthropy Powers Global Reach of CHU Sainte-Justine and Université de Montréal in Pediatric Cardiology

Related Organization(s)

CHU Sainte-Justine

    Also from this source

  • Launch of the CHU Sainte-Justine Centre d'expertise sur les maladies rares médiées par le complément

Fondation Charles-Bruneau

Contact Cision

  • 866-245-2317
    from 8 AM - 10 PM ET
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media

Products

  • Cision Communications Cloud®
  • Media Monitoring
  • Content Distribution
  • Multimedia Distribution
  • Measurement & Analytics
  • Investor Relations

About

  • About Cision Canada
  • About Cision
  • Media Partners
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Online Member Centre
  • Next Gen Communications Cloud
  • Cision Communications Cloud®
  • my CNW

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Centre
  • Next Gen Communications Cloud
  • Cision Communications Cloud
  • my CNW
877-269-7890
from 8 AM - 10 PM ET
  • Terms of Use
  • Information Security Policy
  • Site Map
  • Cookie Settings
  • Accessibility Statement
Copyright © 2025 CNW Group Ltd. All Rights Reserved. A Cision company.